[ad_1] 3M’s current spin-off of its healthcare subsidiary, Solventum Company, indicators a strategic shift geared toward streamlining its operations and unlocking potential worth for shareholders. Regardless of preliminary market enthusiasm, issues persist concerning 3M’s monetary well being and profitability outlook for 2024. Analysts stay divided... Continue reading